Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: J Endocrinol. 2020 Jan;244(1):237–247. doi: 10.1530/JOE-19-0259

Figure 4. Effects of nifedipine (500 nmol/L) or TTA-P2(2 μmol/L) on CaV3.2/3 and CaV1.2 /3 channel currents in H295R cells.

Figure 4

A, Effects of L-type Ca2+ channel inhibitor nifedipine and T-type Ca2+ channel inhibitor TTA-P2 on CaV3.2 channel currents (n = 6). B, Effects of 500 nmol/L nifedipine and 2 μmol/L TTA-P2 on CaV3.3 channel currents(n = 5). C, Effects of 500 nmol/L nifedipine and 2 μmol/L TTA-P2 on CaV1.2 channel currents(n = 5). D, Effects of 500 nmol/L nifedipine and 2 μmol/L TTA-P2 on CaV1.3 channel currents(n = 5). Calcium currents were elicited by a 50-ms depolarizing pulse to −20 mV from a holding potential of −90 mV at 10 s intervals.